Purification of coenzyme Q10 from fermentation extract:: High-speed counter-current chromatography versus silica gel column chromatography

被引:39
作者
Cao, Xue-Li
Xu, Ya-Tao
Zhang, Guang-Ming
Xie, Sheng-Meng
Dong, Ying-Mao
Ito, Yoichiro [3 ]
机构
[1] Beijing Technol & Business Univ, Sch Chem & Environm Engn, Beijing Key Lab Plant Resource Res & Dev, Beijing 100037, Peoples R China
[2] Chinese Acad Space Technol, Space Biol Lab, Beijing 100081, Peoples R China
[3] NHLBI, Ctr Biochem & Biophys, NIH, Bldg 50,Rm 3334, Bethesda, MD 20892 USA
关键词
high-speed counter-current chromatography (HSCCC); coenzyme Q(10); purification;
D O I
10.1016/j.chroma.2006.05.083
中图分类号
Q5 [生物化学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
High-speed counter-current chromatography (HSCCC) is applied to the purification of coenzyme Q(10) (CoQ(10)) for the first time. CoQ(10) was obtained from a fermentation broth extract. Anon-aqueous two-phase solvent system composed of heptane-acetonitrile-dichloromethane (12:7:3.5, v/v/v) was selected by analytical HSCCC and used for purification of CoQ(10) from 500 mg of the crude extract. The separation yielded 130 mg of CoQ(10) at an HPLC purity of over 99%. The overall results of the present studies show the advantages of HSCCC over an alternative of silica gel chromatography followed by recrystallization. These advantages extend to higher purity (97.8% versus 93.3%), recovery (88% versus 74.3%) and yield (26.4% versus 23.4%). An effort to avoid the toxic, expensive solvent CH2Cl2 was unsuccessful, but at least its percentage is low in the solvent system. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:92 / 96
页数:5
相关论文
共 20 条
[1]
Coenzyme Q10 as a possible treatment for neurodegenerative diseases [J].
Beal, MF .
FREE RADICAL RESEARCH, 2002, 36 (04) :455-460
[2]
Potential role of ubiquinone (coenzyme Q10) in pediatric cardiomyopathy [J].
Bhagavan, HN ;
Chopra, RK .
CLINICAL NUTRITION, 2005, 24 (03) :331-338
[3]
FOLKERS K, 1985, DRUG EXP CLIN RES, V11, P539
[4]
Gaby A.R., 1996, ALT MED REV, V1, P11
[5]
Gaby AR, 1996, ALTERN MED REV, V1, P168
[6]
Naturoceutical agents in the management of cardiovascular disease [J].
Hermann D.D. .
American Journal of Cardiovascular Drugs, 2002, 2 (3) :173-196
[7]
Hojerova J, 2000, Ceska Slov Farm, V49, P119
[8]
HOSTETTMANN K, 1998, PREPARATIVE CHROMATO, P170
[9]
Jones K, 2004, ALTERN THER HEALTH M, V10, P22
[10]
Statins, cholesterol, Co-enzyme Q10, and Parkinson disease [J].
Lieberman, A ;
Lyons, K ;
Levine, J ;
Myerburg, R .
PARKINSONISM & RELATED DISORDERS, 2005, 11 (02) :81-84